OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-09-30-accounts

Registered number: 04307833 Charity number: 1103852

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

UNAUDITED

TRUSTEES' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2022

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

CONTENTS

Page
Reference and Administrative Details of the Charity, its Trustees and Advisers 1
Trustees' Report 2 - 17
Independent Examiner's Report 18 - 19
Statement of Financial Activities 20
Balance Sheet 21 - 22
Notes to the Financial Statements 23 - 37

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 30 SEPTEMBER 2022

Trustees

Professor R N A Henson, Chair Dr M C Ashby, Trustee (appointed 20 May 2022) Dr M Berners, Trustee Professor C M Bird, Trustee (appointed 20 May 2022) Dr T J Bushell, Trustee (appointed 20 May 2022) Dr K P Cox, Trustee Professor A C Dolphin, Trustee Professor C J Harmer, Trustee (Resigned 20 May 2022) Professor A R Isles, Trustee (resigned 20 May 2022) Professor Z Kourtzi, Trustee - Professor A R Lingford Hughes, Trustee (resigned 20 May 2022) Professor A M Palmer, Trustee Professor N Ramnani, Trustee (resigned 20 May 2022) - Professor T L Spires Jones, Trustee Dr V Straub, Trustee Dr M E Walton, Trustee (appointed 20 May 2022)

Company registered number

04307833

Charity registered number

1103852

Registered office

Dorothy Hodgkin Building Whitson Street Bristol BS1 3NY

Company secretary

Dr A Cooke

Chief executive officer

Dr A Cooke

Accountants and Independent Examiner

Martin Bailey FCA Goodman Jones LLP Chartered Accountants 29/30 Fitzroy Square London W1T 6LQ

Page 1

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A company limited by guarantee)

REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS

Trustees

Professor R. Henson(President,and Officer) appointed April 2021
Professor Z. Kourtzi(Association Secretary,and Officer) elected January2019
Professor C. Harmer (Treasurer and Officer) elected June 2017 – term of office
ended May2022
Dr T. Bushell(Treasurer and Officer) Elected May2022
Professor Tara Spires-Jones(President Elect) Appointed May2021
Professor A. Dolphin(Immediate Past President) Appointed May2021
Dr V. Straub(Groups Co-ordinator) elected May2022
Professor N. Ramnani (Research Policy) Elected June 2017 – term of office
ended May2022
Professor C. Bird(Research Policy) Elected May2022
Professor A. Lingford-Hughes (Professional Liaison) Elected June 2017 – term of office
ended May2022
Professor A. Isles (Communications) Elected June 2017 – term of office
ended May2022
Professor M.Walton(Preclinical Research) elected May2022
Dr M. Ashby (Credibilityin Neuroscience) elected May2022
Dr M Berners, (Independent Trustee) Appointed April 2017. Re-appointed
May2022
Dr K P Cox, (Independent Trustee) Appointed April 2017. Re-appointed
May2022
Professor A M Palmer, (Independent Trustee) Appointed April 2017. Re-appointed
May2022

Company registered number: 04307833 Charity registered number: 1103852

Registered office: The BNA Office, Dorothy Hodgkin Building, Whitson Street, Bristol BS1 3NY

Accountants: Goodman Jones LLP, Chartered Accountants, 29/30 Fitzroy Square, London W1T 6LQ

2

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A company limited by guarantee) TRUSTEES’ REPORT FOR THE YEAR ENDED 30 SEPTEMBER 2022

The Trustees present their annual report together with the financial statements for the year 1 October 2021 to 30 September 2022.

The Annual Report serves the purposes of both a Trustees' Report and a Directors' Report under company law. The Trustees confirm that the Annual Report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).

Since the Charity qualifies as small under section 382 of the Companies Act 2006, the Strategic Report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted.

Our vision and purpose:

The BNA is a membership organisation committed to preserve and protect health and advance public engagement in neuroscience, through supporting, promoting and representing neuroscientists and neuroscience research.

Our objects:

The Association's objects (The Objects), as formulated in the Articles of the Association (Article 4) and in the Rules of the Association (Rule 1.3), both documents coming into force in April 2017, are:

To preserve and protect health and advance public education in neurosciences related to health and disease, in particular but not exclusively) by:

(a) Promoting on a multidisciplinary basis the study of the development structure and function of the nervous system in health and disease;

(b) Promoting the dissemination of information to all those interested in the neurosciences and related disciplines by means of lectures, discussions, meetings and reports from time to time obtained from such researchers;

(c) Advising as far as possible on issues in neurosciences related to health and disease;

(d) Endeavouring to increase public awareness and understanding of neuroscience research in health and disease;

(e) Assisting in the training of neuroscientists and other professionals engaged in neuroscience teaching and research;

3

(f) Representing the interests of neuroscience researchers and promoting the case for the advancement of neuroscience research in the United Kingdom to government, to agencies providing research funding and to bodies engaged in science administration, regulation and standards.

All trustees had due regard to the Charity Commission's public benefit guidance when exercising powers and duties on behalf of the charity.

Our aims:

We have three interconnected aims that are central to achieving our vision and purpose, and are the means by which we deliver our objectives: these are to Inform, Connect, and Influence. The aims to Inform, Connect and Influence , were arrived at through a series of strategic workshops and engagement with members, and they help the BNA Council and Committee to direct activities throughout the year.

Message from the Chair and Chief Executive October 2021-September 2022

Entering into October 2021, the BNA community had substantially returned to ‘normal’ life in labs, schools and offices, having spent the previous 18 months navigating different levels of precautions and restrictions due to the COVID-19 pandemic. For many people, including many of the BNA members, this had been a very mixed time. Some embraced greater time at home, others struggled with isolation or separation from family, and the consequences of school closures, illness, mental wellbeing and bereavement continue to reverberate today.

Given the previous period of restrictions, the BNA’s year therefore started with optimism and plans to recommence in-person meetings and embrace a post-COVID world. Before barely two months had passed, the Omicron variant put much of the UK back in lock-down. Even though this turned out to be the final lock-down, this inevitably meant that our YE2022 reporting period continued to be affected by the uncertainty and disruption experienced in YE2020 and YE2021.

Regardless, the year has plenty of activities to report. Highlights include the growth of the BNA Scholars Programme; bringing together the European neuroscience community to keep European neuroscience collaboration open post-Brexit; and even launching a podcast. As described in the following report, our meetings included both in-person and online, with a high degree of responsiveness and flexibility continuing to be the norm.

A major panacea to any uncertainty was receiving a second substantial grant from the Gatsby Charitable Foundation. The first grant allowed us to significantly expand the BNA’s activities and impact. With the grant coming to an end during YE2022, securing further funding was a top priority for the year. We are very grateful to the Gatsby for awarding another three year grant, taking us to September 2025. This will enable us to embed progress made to date, and lead us into the next phase of creating ‘an exciting and sustainable future for 21[st] century neuroscience’.

4

Report of the Board of Trustees

Aim 1: Inform

Scientific Journal : The Association’s scientific journal, Brain and Neuroscience Advances , is the platform through which we inform the profession about the latest neuroscience research. Following the Journal’s successful indexing in PubMed Central (PMC) in April 2020, all articles are included on PMC’s searchable database, giving wide visibility and availability worldwide. In addition, the fact that the Journal is Gold Open Access means all content is completely accessible by readers free of charge. The journal is published by Sage and wholly owned by the BNA, and continues to benefit from excellent leadership by Editor-in-Chief Jeff Dalley along with an international editorial board.

Highlights over the reporting period include:

The number of articles published in the journal between 1st Oct 2021 – 30th Sept 2022 was as follows:

Informing members: Keeping our members informed is an essential role performed by the BNA, whether that’s informing each other about the BNA community’s ‘internal’ activities or informing them about external factors that are relevant to the field as a whole.

Our printed members’ newsletter, The BNA Bulletin , is sent out three times a year and informs members about events, prizes, news from the BNA, funders or regulators, and activities across the BNA community, as well as highlighting research undertaken by UK neuroscientists. Brain Insights is a section within the Bulletin written by and for students and Early Career Researchers, offering a valuable opportunity for early career scientists to gain writing experience. The Bulletin now also includes a regular feature on policy, written by the BNA’s Head of Policy and Campaigns, which ensures members are kept up to date with issues such as European Union funding negotiations, and changes in UK government that impact science.

Alongside the Bulletin members receive a monthly email newsletter, the eBulletin. This provides more frequent updates on BNA activities, jobs, events and funding.

Social media platforms are also now very important ways to keep our members informed, as they enable immediate, specific and direct interaction between the BNA office and our wider community (see more below).

5

During this reporting period a new communications route was launched for BNA members, namely a BNA ‘Slack’ group. This was established due to the desire of members to have an easy and instant way to contact each other and keep each other informed about research, jobs, teaching or anything else relevant to their roles in neuroscience. The Slack group is exclusive to BNA members, creating another membership benefit.

External communications : The website and the BNA’s social media platforms are increasingly well-used resources for informing people about neuroscience, reaching both members and non-members. These digital communication channels make the BNA readily accessible to members of the public, and the office is kept busy answering enquiries from journalists, patients, prospective students and anyone else wanting to know about neuroscience.

During 2021-2022 the website attracted 161.6k users and 459k page views. This compares to 154k users and 486k page views in the period 2020-2021. Pages with information on jobs, careers and courses consistently remains the most visited of the site, showing how the BNA is used as a way to find out how to study and pursue a career in neuroscience.

By the end of this reporting period, the BNA had 34k (Twitter), 13.3k (Facebook), 14.6k (LinkedIn), 2.8k (Instagram) and 3.4k (YouTube) followers across social media channels.

Public engagement of neuroscience : The BNA’s main public engagement activity takes place every other year, via the Festivals of Neuroscience. This reporting period does not include a Festival, but a number of public-facing activities still took place.

The BNA’s annual Festive symposium is always designed to be accessible by members of the public as well as neuroscientists. Due to ongoing travel restrictions and disruption caused by COVID-19, the 2021 event was held online for the second year running. However, being online has the benefit of increasing accessibility to a wider audience, both geographically and to those working outside of neuroscience.

This year’s Festive symposium was entitled “Ding Dong Merrily on AI”, launching the BNA’s annual theme for 2023 - the neuroscience of Artificial Intelligence (AI).

During the global ‘Brain Awareness Week’ campaign (March 2022) we again picked up on the AI theme, via a series of articles and social media posts.

In a first for the BNA, we also forayed into podcasts. ‘Embodied AI’ is a podcast developed and run by one of the BNA’s placement students, featuring interviews with leading researchers in the field. It hosted three episodes during the reporting period, bringing a new audience to the BNA.

Aim 2: Connect

Connecting the neuroscience community through BNA membership : over the course of YE2022 we saw membership make a modest but important increase from 2,466 to 2,621 (+155). To put this increase in context, the graph below shows total membership over the previous six years (total increase 1,344 to 2,621, or 195%).

6

The membership types with greatest percentage increase growth over YE2022 were those at earlier career stages, particularly student/undergraduate (119%) and career starter (153%, see table below). Having a growing community of early career members is one reason why the Association is making career development one of its priority areas, as this is clearly an area of need for our members and one where the BNA can have a positive impact on developing the sector.

YE2021 YE2022 Change %
Full Members 594 592 -2 100%
Early Career Researchers 311 307 -4 99%
Career starter 19 29 +10 153%
Postgraduate 615 623 +8 101%
Student/Undergraduate 749 894 +145 119%
Industry member 47 50 +3 106%
Associate member 73 70 -3 96%
Retired member 52 50 -2 96%
Honorary member 6 6 0 100%
TOTAL 2,466 2621 +155 106%

BNA Local Groups: The BNA has a national network of Local Groups (LGs) each headed by a Local Group Representative (LGR). Many groups also have one or more Local Group Student Representatives (LGSRs). This network enables two-way communication between members and the BNA Council, provides local hubs for members, and an important way for members to connect with colleagues near and far. The LGRs do a great deal to help the BNA connect and support neuroscientists, and the Association is very grateful for their work.

During YE2022, the LG network received a boost thanks to appointing a new full time member of staff as ‘BNA Community and Inclusion Officer’, with a particular focus on supporting the BNA community of members. In September 2022, the LGRs and LGSRs met in Leicester for a Local Group Forum, the first time they were able to meet in-person for since before the pandemic. Amongst other activities, the day enabled a discussion on the teaching of neuroscience, something which has changed radically over the last two years. sharing experience and best practice in this way is hugely valuable for the community. aAlongside the in-person meeting, the online monthly meetings of LGRs have also continued.

7

LGs can apply for BNA funding to support local activities which help promote the aims and objectives in the BNA. LG activities taking place during YE2021 included:

In addition, special funding was made available to LGs in this reporting period, following the last-minute cancellation of the large Society for Neuroscience (SfN) meeting in the United States. This meeting is extremely important for, in particular, students and early career neuroscientists, and its late cancellation was detrimental for them both financially and for career development. The BNA therefore made funds available so that LGs could hold group gatherings and enable those who had been affected by the cancellation to at least have a local audience for posters and talks. A number of these special meetings were held across the UK and proved very popular, with some LGs in Northwest England now planning to hold a regional meeting annually.

Connecting with industry (‘Building Bridges Between: Industry and Academia’ (BBB)): Our strategic programme to increase connections between neuroscience in these two sectors continues to strengthen and grow. Four highlights of this programme of work during the reporting period are as follows:

8

and improve understanding of, and treatment of, psychiatric disorders.

4) Annual partnership models

BNA Meetings : Bringing people together via events is essential for the BNA to fulfil its aim to connect. Through our meetings we enable neuroscientists to connect with each other, across disciplines and geographies, and goes towards meeting our object to “disseminate information to all those interested in the neurosciences and related disciplines”.

YE2022 continued to be affected by COVID-19, and so all but one of the meetings in the reporting period were held online. However, the first post-pandemic in-person meeting was held in May 2022 at the Sainsbury Wellcome Centre in London (the ‘BBB’ workshop on improving translation in neuroscience, see above).

The largest meeting of the year was also a first for the BNA: a members-only event, intentionally exclusive to BNA members to encourage open sharing in a supportive and safe online environment. Held over two days, an astonishing 42 speakers took part, talking about everything rom learning in worms to gambling addiction, and from brain organoids to developing drugs for migraines. There was also a special session on women in neuroscience. The Members’ Meeting was warmly received, and we plan to hold again in years between the biennial Festival of Neuroscience.

A list of all meetings held through the reporting period is as follows:

9

Membership of societies: The BNA is a member of three organisations which make sure the BNA membership is part of a larger voice. Membership of the Royal Society of Biology (RSB) connects us with all the life sciences across the UK. The Federation of European Neuroscience Societies (FENS) enables the BNA and BNA members to be part of European neuroscience, and membership of the International Brain Research Organisation (IBRO) connects the BNA with the global community.

Of the three organisations, the BNA is most actively involved in FENS. The BNA is a member of the FENS Governing Council, and was represented at FENS meetings through the year. This included attendance of the 2022 FENS Forum, in Paris, France. The BNA president and president-elect both took part and a large gathering of BNA members got together for a members’ social. BNA CE represented the Association at the Governing Council and spoke on the BNA Scholars Programme (see more in Aim 3).

Aim 3: Influence

As the largest UK-based organisation representing neuroscience and neuroscientists, the BNA is in position to influence the sector, decision-makers, and neuroscientists themselves. Having influence is central in fulfilling two of the Association’s objects: (c) Advising as far as possible on issues in neurosciences related to health and disease; and (f) Representing the interests of neuroscience researchers and promoting the case for the advancement of neuroscience research in the United Kingdom to government, to agencies providing research funding and to bodies engaged in science administration, regulation and standards.

Our main areas of activity in the area of ‘influence’ are listed below.

Credibility in neuroscience : We are now three years into our core campaign to, “support the neuroscience sector to increase the transparency, reproducibility, replicability and reliability of neuroscience research”. The credibility in neuroscience campaign requires the BNA to influence both ways: to influence neuroscientists and how neuroscience is done, but also to influence the organisations and environment in which neuroscientists operate, so that the way neuroscience is done is able to change. Some key achievements during the reporting period:

10

complete reporting free from biases, changing incentive structures in research, and changing hiring practices so that they value reproducibility and Open Science.

Equity, diversity and inclusion (EDI) in neuroscience: The role the BNA has in this space continues to grow, and the Association is committed to influencing and increasing EDI in our sector.

The most significant piece of work in terms of resources (financial, staff, and volunteer time) is running the BNA Scholars Programme. Going into its second year during YE2022, the programme welcomed a further seven scholars meaning that it supported fourteen students and Early Career Researchers from under-represented ethnic groups to flourish in neuroscience. With more momentum, supporters and being able to meet in person, activities for the scholars were able to expand and included: a bespoke careers day at COMPASS Pathways; attendance of the Federation of European Neuroscience Societies (FENS) Forum in Paris; one-to-one mentorship of all scholars.

It is important to also advocate for change in the institutions and systems that can continue to discriminate against individuals due to sex, ethnicity, disability, wealth, background or other characteristics that make up who we are, and the BNA will continue to contribute to change in neuroscience wherever it can. In response to an inquiry of the House of Commons Science and Technology Committee, asking about the implications of a lack of diversity in research and considering measures taken to improve diversity within the field thus far, the BNA therefore submitted in which we presented data collected in recent years on diversity within neuroscience research. These were particularly informed by our 2021 Festival which, having been held online, gave us a much larger and comprehensive snapshot sample of the neuroscience research community.

The data we presented indicate an underrepresentation of black groups in neuroscience research compared to the general population, and that representation of ethnic minority groups, women and people who identify as non-binary decreases with seniority of research role. We also supported evidence submitted by our Trustee for Research Policy, Narender Ramnani, in which data from Freedom

11

of Information requests enabled a deep and thorough analysis of ethnic minority representation on Research Councils’ committees, revealing persistent underrepresentation over the last five years.

Other EDI activities included a spotlight on ‘Women in Neuroscience’ at the Members’ Meeting via a dedicated panel session, and we have continued to award ‘Carer Grants’ (supported by the Guarantors of Brain) which enable those with caring responsibilities to participate in neuroscience activities by e.g. paying for childcare or help for elderly relatives.

A voice in Parliament: The BNA is a member of the Parliamentary and Scientific Committee (P&SC). This committee is an interface between scientists and parliamentarians and provides opportunities for the BNA to inform decision-making that takes place in both the House of Commons and the House of Lords, and enables us to raise awareness of issues that we feel are important for neuroscientists. The BNA was represented at P&SC meetings throughout the year.

A highlight of the year was holding an event for parliamentarians, members, funders and other stakeholders. Entitled, “Brain Gain: How world-leading UK neuroscience research can meet tomorrow’s societal challenges” the online event raised the profile of neuroscience, and highlighted to decisionmakers its importance in helping tackle the UK’s big health challenges. The event was very well-attended and subsequently reported in the publication for MPs ‘Science in Parliament’.

Post-Brexit neuroscience - bringing together the European neuroscience community on UK membership of Horizon Europe: In response to the ongoing delays in the UK and EU agreeing UK associate membership of the EU’s world-leading research and innovation Horizon Europe programme, the BNA coordinated a letter from 34 presidents of member organisations of FENS urging the President of the European Commission, Dr Ursula von der Leyen, to confirm UK membership to help keep European neuroscience collaboration open. This represented a united message highlighting concerns the European neuroscience community have over the current delay of UK association to Horizon Europe. The letter, while not resolving the UK Horizon Europe issue, helped add to the pressure exerted by the research sector around Horizon Europe during a period of significant political uncertainty at a UK level.

Green neuroscience: A new policy area for the BNA is that of the environmental sustainability of neuroscience research, or ‘green neuroscience’. Following discussions at the BNA 2021 Festival of Neuroscience, a new Green Neuroscience Working Group was formed with four main areas of activity: (1) making sure the way the BNA itself is as environmentally responsible as possible; (2) reducing the impact of neuroscience research;(3) encouraging change at institutional level and (4) supporting individuals to make changes to reduce their own environmental impact.

Animals in Research : The BNA continues to be committed to openness on the use of animals in research and is a signatory of the Concordat on Openness on Animal Research in the UK. We are an active member of the RSB Animal Science Group, a special interest group representing the broad spectrum of UK bodies actively involved in supporting, funding, or formulating policy on research involving animals.

BNA prizes: Last but by no means least, another way of influencing neuroscience is by recognising and celebrating its achievements. Winners of the BNA’s annual prizes in YE2022 were as follows:

12

Plans for 2022/23 (YE2023)

The strategic pillars of the BNA remain ‘Inform, Connect, Influence’, with the ‘Credibility in Neuroscience’ continuing as our core 5-10 year commitment underlying all our activities.

At the start of YE2023, priorities are as follows:

  1. Appointing a new Chief Executive (CE): At the time of writing, the current CE (Anne Cooke) will leave the position after 7.5 years in the role. A major priority for the BNA is therefore managing the transition to the new CE (who has recently been identified) and taking advantage of new leadership to capitalise on the BNA’s secure position to facilitate greater growth and success.

  2. Professionalising the sector: At present, there are no agreed, universal standards for undergraduate or postgraduate neuroscience courses to meet, making the quality of courses range widely and meaning future neuroscientists have no way of identifying ones that will provide a good grounding for their career. As the leading professional organisation for neuroscience, we plan to establish a way of assessing and endorsing neuroscience courses.

  3. Including and catering for clinical neuroscientists: We wish to improve how we include those individuals who are both clinically trained and have research interests in neuroscience, across the three main specialities of neurology, psychiatry and psychology.

  4. Providing career development advice and opportunities: with an ever-growing membership of students and early career researchers, the BNA is in a unique position to provide them with connections and opportunities beyond their own institutions and across the sector.

  5. Reaching a wider audience: We know from surveys and anecdotally that many people who could be a member of the BNA, do not know about the Association nor what we do. We will seek to address this by investing in marketing and communications during YE2023.

  6. Further strengthening collaboration between academic and commercial sectors: The BNA has taken great strides in building links between the sectors via its ‘BBB’ programme. It is now poised and ready to take this to the next level, as well as broaden into more medtech as well as pharmaceutical areas of industry.

13

Review of financial position

a. Going concern

After making appropriate enquiries, the Trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. For this reason they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the Accounting Policies.

b. Financial review

During the financial year ending 30th September 2022 the BNA’s total income was £407,416. Expenditure, which was wholly on charitable activities to advance education in neuroscience, was £319,236; after taking account of net losses on investments, the net movement in funds was a surplus of £54,121.

The net reserves carried forward was £597,731. Of this, around £85,000 is held in restricted funds, committed largely to (1) delivering activities associated with funding from the Gatsby Charitable Foundation, and (2) supporting the BNA’s equity, diversity and inclusion work.

Funding has and will continue to be used to support the BNA Trustees’ ten-year strategic plan, in particular the ‘Credibility in Neuroscience’ campaign, but also other activities which meet the aims to ‘Inform, Connect and Influence’.

The BNA remains in a stable financial position to sustain itself and to meet its charitable objectives.

.c. Reserves policy

The BNA’s reserves policy states that unrestricted funds which have not been designated for a specific use should be maintained at a level equivalent to one year’s expenditure, where one year’s expenditure is calculated on the basis of:

The Trustees consider that reserves at this level will ensure that, in the event of a significant drop in revenue, they will be able to continue the Association’s current activities while consideration is given to ways in which additional funds may be raised and/or costs can be reduced. The level of this reserve will be maintained throughout the course of each accounting year.

d. Principal funding

The main sources of income for the BNA in Year End 2022 were membership subscriptions (£100k), dividend received from the BNA’s subsidiary company, BNA Events Ltd (£98.5k) and grants and donations (£207.7k, with £150k of this from The Gatsby Charitable Foundation). Overall, around half the BNA’s principal funding is from membership and events, and half from donations.

14

e. Investment policy and objectives

The Trustees’ investment powers are governed by Article 5 in the Articles of Association. This permits the Charity to deposit or invest funds in securities or property as may be thought fit in order to further its Objects, or is conducive or incidental to doing so, subject to conditions and consents as laid down in the Association’s governing documents.

During YE2022, the Trustees made the decision that the BNA should not invest in activities associated with gambling. This is in addition the previous year’s decision to not hold more than a total of 5% investments in tobacco, alcohol, or firearms (combined). The target is to reduce such investments to 0%.

The Trustees’ policy for YE2022 will be to continue to optimise income on temporarily invested funds and to maintain a balanced portfolio of long-term investments, and continue to manage the charity’s investments in conformity with our policy and Trust Deed.

Structure, governance and management

a. Constitution

British Neuroscience Association Limited is a company limited by guarantee, as defined by the Companies Act 2006. The Company is registered as a charity under the registration number 1103852.

The BNA is governed by its Memorandum and Articles of Association, and accompanying set of Rules. These were revised during the period of the previous report, and the new documents approved by the Charity Commission in June 2017. No changes have been made to governing articles since then.

b. Organisational structure

The British Neuroscience Association is a membership organisation, with seven membership categories (defined in the Rules), plus a number of Honorary members. With the exception of Associate members, all members have voting rights on the principle of “one member, one vote”, which is exercised at the Annual General Meetings (detailed in Articles 15-27).

The association has 39 Local Groups (Rule 5), that provide for a national network between members and the Association’s governance team.

The BNA is governed by a Council of Trustees, comprising between seven and twelve members of the Association (Article 29). Non-Trustee positions on the Council include the Meetings Secretary, other coopted members for specific functions and other invited observers or advisors, for example the Neurology Advisor. The specific procedures for the appointment and retirement of the Trustees are detailed in the Articles (32-35).

To help with discharging the activities of the Association, the BNA has also a National Advisory Committee (formerly “The National Committee”) whose role is to represent different demographics and interests within the Association’s membership (Rule 4).

Supporting all activities and needs of the Council, Committee, and general membership is the BNA Executive. During the year this consisted of one full time and three part-time staff members.

15

c. Risk management

The trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error. Potential risks, once identified, will be monitored and controlled to mitigate any impact that they may have on the Association in the future.

To help with this the BNA has a Risk Register. Conflict of Interest (Rules 8 and 9) and a Register of Interests. BNA has a specific Declaration of Interests form, that is completed by all members of the Council and Committee of the BNA.

Statement of Trustees’ responsibilities

The Trustees (who are also directors of British Neuroscience Association Limited for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial year. Under company law the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charitable company's transactions and disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

16

Reference and administrative details

Members of BNA Council (on 30[th] September 2022)

appointed April 2021 elected May 2022 appointed April 2021 appointed April 2021 elected May 2020 elected May 2022 elected May 2022 elected May 2022 appointed April 2017 appointed April 2017 appointed April 2017 appointed October 2019 appointed October 2021

Members of the National Committee

Elected Sept 2018 Elected June 2020 Elected February 2019 Appointed May 2022 Appointed May 2022 Appointed May 2022

Executive

Approved by order of the members of the Board of Trustees and signed on their behalf by:

……………………………………….

Professor R N A Henson Chair

Date:[04-05-23]

17

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 30 SEPTEMBER 2022

Independent Examiner's Report to the Trustees of British Neuroscience Association Limited ('the Charity')

I report to the charity Trustees on my examination of the accounts of the Charity for the year ended 30 September 2022.

Responsibilities and Basis of Report

As the Trustees of the Charity (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the Charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the Charity's accounts carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent Examiner's Statement

Since the Charity's gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of Institute of Chartered Accountants in England and Wales, which is one of the listed bodies.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

  1. accounting records were not kept in respect of the Charity as required by section 386 of the 2006 Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination; or

  4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)].

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

This report is made solely to the Charity's Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the Charity's Trustees those matters I am required to state to them in an Independent Examiner's Report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the Charity and the Charity's Trustees as a body, for my work or for this report.

Page 18

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

INDEPENDENT EXAMINER'S REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2022

Signed:

Dated: 04-05-23

Martin Bailey FCA Goodman Jones LLP 29/30 Fitzroy Square London W1T 6LQ

Page 19

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 30 SEPTEMBER 2022

Note
Income from:
Donations and legacies
4
Charitable activities
5
Investments
6
Total income
Expenditure on:
Charitable activities
7
Total expenditure
Net income/(expenditure) before net
(losses)/gains on investments
Net (losses)/gains on investments
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Net movement in funds
Total funds carried forward		 Unrestricted
funds
2022
£
4,558
101,222
98,493
204,273
149,939
149,939
54,334
(34,059)
20,275
491,954
20,275
512,229		 Restricted
funds
2022
£
203,143
-
-
203,143
169,297
169,297
33,846
-
33,846
51,656
33,846
85,502		 Total
funds
2022
£
207,701
101,222
98,493
407,416
319,236
319,236
88,180
(34,059)
54,121
543,610
54,121
597,731		 Total
funds
2021
£
65,046
98,224
227
163,497
250,750
250,750
(87,253)
62,111
(25,142)
568,752
(25,142)
543,610

The Statement of Financial Activities includes all gains and losses recognised in the year.

The notes on pages 23 to 37 form part of these financial statements.

Page 20

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee) REGISTERED NUMBER: 04307833

BALANCE SHEET AS AT 30 SEPTEMBER 2022

Note
Fixed assets
Tangible assets
11
Investments
12
Current assets
Debtors
13
Cash at bank and in hand
Creditors: amounts falling due within one
year
14
Net current assets
Total assets less current liabilities
Total net assets
Charity funds
Restricted funds
15
Unrestricted funds
15
Total funds		 57,722
229,129
286,851
(19,693)		 2022
£
1,353
329,220
330,573
267,158
597,731
597,731
85,502
512,229
597,731		 82,895
106,995
189,890
(11,362)		 2021
£
1,803
363,279
365,082
178,528
543,610
543,610
51,656
491,954
543,610

The Charity was entitled to exemption from audit under section 477 of the Companies Act 2006.

The members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.

Page 21

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee) REGISTERED NUMBER: 04307833

BALANCE SHEET (CONTINUED) AS AT 30 SEPTEMBER 2022

The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:

................................................

Professor R Henson President

Date: 04-05-23

The notes on pages 23 to 37 form part of these financial statements.

Page 22

BRITISH NEUROSCIENCE ASSOCIATION LIMITED (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2022

1. General information

British Neuroscience Association Limited is a Charitable Company Registered in England and Wales. The registered office address is Dorothy Hodgkin Building, Whitson Street, Bristol BS1 3NY.

The Charity is a company limited by guarantee. The members of the company are the Trustees named on page 1. In the event of the Charity being wound up, the liability in respect of the guarantee is limited to £1 per member of the Charity.

2. Accounting policies

2.1 Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

British Neuroscience Association Limited meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

The financial statements are prepared in sterling, which is the functional currency of the Charity. Monetary amounts in these financial statements are rounded to the nearest £.

2.2 Going concern

After making appropriate enquiries, the Trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. The Trustees have considered the future plans of the Charity and expected income, and it is deemed that the Charity can meet its commitments and liabilities and can continue for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

2.3 Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charity and which have not been designated for other purposes.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Charity for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.

Investment income, gains and losses are allocated to the appropriate fund.

Page 23

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2022

2. Accounting policies (continued)

2.4 Income

All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

Other income is recognised in the period in which it is receivable and to the extent the goods have been provided or on completion of the service. Membership fees are recongised in the period to which they relate.

Grant income is recognised when the Charity has entitlement to the funds, any performance conditions attached to the grants have been met, it is probable that the income will be received, and the amount can be measured reliably.

Grants, including government grants, are included in the Statement of Financial Activities on a receivable basis. The balance of income received for specific purposes but not expended during the period is shown in the relevant funds on the Balance Sheet. Where income is received in advance of entitlement of receipt, its recognition is deferred and included in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued.

2.5 Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Charity; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.

2.6 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the Charity's objectives, as well as any associated support costs.

Grants payable are charged in the year when the offer is made except in those cases where the offer is conditional, such grants being recognised as expenditure when the conditions attaching are fulfilled. Grants offered subject to conditions which have not been met at the year end are noted as a commitment, but not accrued as expenditure.

All expenditure is inclusive of irrecoverable VAT.

Page 24

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2022

2. Accounting policies (continued)

2.7 Government grants

Government grants relating to tangible fixed assets are treated as deferred income and released to the Statement of Financial Activities over the expected useful lives of the assets concerned. Other grants are credited to the Statement of Financial Activities as the related expenditure is incurred.

2.8 Tangible fixed assets and depreciation

Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost.

Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

2.9 Investments

Fixed asset investments are a form of financial instrument and are initially recognised at their transaction cost and subsequently measured at fair value at the Balance Sheet date, unless the value cannot be measured reliably in which case it is measured at cost less impairment. Investment gains and losses, whether realised or unrealised, are combined and presented as ‘Gains/(Losses) on investments’ in the Statement of Financial Activities.

Investments in subsidiaries are valued at cost less provision for impairment.

2.10 Debtors

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

2.11 Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

Page 25

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2022

2. Accounting policies (continued)

2.12 Liabilities and provisions

Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the Charity anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.

Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of Financial Activities as a finance cost.

2.13 Financial instruments

The Charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

2.14 Pensions

The Charity operates a defined contribution pension scheme and the pension charge represents the amounts payable by the Charity to the fund in respect of the year.

3. Critical accounting estimates and areas of judgement

Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Critical accounting estimates and assumptions:

The Charity makes estimates and assumptions concerning the future. The resulting accounting estimates and assumptions will, by definition, seldom equal the related actual results. No estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year have been identified.

Page 26

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2022

4. Income from donations and legacies

Donations
Government grants
Total 2021		 Unrestricted
funds
2022
£
4,558
-
4,558
44,880		 Restricted
funds
2022
£
203,143
-
203,143
20,166		 Total
funds
2022
£
207,701
-
207,701
65,046		 Total
funds
2021
£
63,312
1,734
65,046

Government grants in the prior year represents monies received under the UK Government's Coronavirus Job Retention Support Scheme.

5. Income from charitable activities

Subscriptions and Bulletin advertising
Total 2021		 Unrestricted
funds
2022
£
101,222
98,224		 Total
funds
2022
£
101,222
98,224		 Total
funds
2021
£
98,224

Page 27

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2022

6. Investment income

Unrestricted
funds
2022
£
Dividend income
98,275
Bank interest
218
98,493
Total 2021
227		 Total
funds
2022
£
98,275
218
98,493
227		 Total
funds
2021
£
-
227
227

7. Analysis of expenditure on charitable activities

Summary by fund type

Advance education in neuroscience
Total 2021		 Unrestricted
funds
2022
£
149,939
115,690		 Restricted
funds
2022
£
169,297
135,060		 Total
2022
£
319,236
250,750		 Total
2021
£
250,750

8. Analysis of expenditure by activities

Advance education in neuroscience
Total 2021		 Activities
undertaken
directly
2022
£
209,517
170,347		 Support
costs
2022
£
109,719
80,403		 Total
funds
2022
£
319,236
250,750		 Total
funds
2021
£
250,750

Page 28

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2022

8. Analysis of expenditure by activities (continued)

Analysis of direct costs

Advance
education in
neuroscience
2022
£
Staff costs
126,108
Bulletin production
24,513
Bursaries and sponsorship
8,151
Gatsby project costs
34,692
Subscriptions and membership
7,556
Advertising
1,600
Travel
1,653
Printing, postage and stationery
768
Journal production
4,476
209,517
Total 2021
170,347		 Total
funds
2022
£
126,108
24,513
8,151
34,692
7,556
1,600
1,653
768
4,476
209,517
170,347		 Total
funds
2021
£
122,302
27,797
2,436
4,407
5,054
1,750
1,153
811
4,637
170,347

Page 29

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2022

8. Analysis of expenditure by activities (continued)

Analysis of support costs

Advance
education in
neuroscience
2022
£
Staff costs
82,735
Depreciation
450
Advertising
866
Travel
6,727
Printing, postage and stationery
110
Telephone
600
Website development
3,872
Professional fees
7,693
Insurance
1,090
Bank charges
2,825
Sundry
751
Governance
2,000
Bad debt
-
109,719
Total 2021
80,403		 Total
funds
2022
£
82,735
450
866
6,727
110
600
3,872
7,693
1,090
2,825
751
2,000
-
109,719
80,403		 Total
funds
2021
£
67,390
450
605
72
131
635
(1,870)
7,267
707
3,086
355
2,000
(425)
80,403

Governance costs represent accountancy and independent examination fees.

9. Staff costs

Wages and salaries
Social security costs
Contribution to defined contribution pension schemes		 2022
£
185,282
14,850
8,711
208,843		 2021
£
169,913
12,158
7,621
189,692

Page 30

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2022

9. Staff costs (continued)

The average number of persons employed by the Charity during the year was as follows:

2022 2021
No. No.
Employees 6 6
No employee received remuneration amounting to more than £60,000 in either year.
Total remuneration, including employer's national insurance and pension contributions, in respect of key
management personnel totalled £58,717 (2021: £56,546).

10. Trustees' remuneration and expenses

During the year, no Trustees received any remuneration or other benefits (2021 - £NIL) .

During the year ended 30 September 2022, no Trustee expenses have been incurred (2021 - £NIL to 0 Trustees ) .

11. Tangible fixed assets

Cost or valuation
At 1 October 2021
At 30 September 2022
Depreciation
At 1 October 2021
Charge for the year
At 30 September 2022
Net book value
At 30 September 2022
At 30 September 2021		 Office
equipment
£
4,355
4,355
2,552
450
3,002
1,353
1,803

Page 31

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2022

12. Fixed asset investments

Cost or valuation
At 1 October 2021
Revaluations
At 30 September 2022
Net book value
At 30 September 2022
At 30 September 2021
Principal subsidiaries
The following was a subsidiary undertaking of the Charity:
Name
Company
number
BNA Events Limited
07784689
The financial results of the subsidiary for the year were:
Name
BNA Events Limited		 Investments
in
subsidiary
companies
Other
investments
Total
£
£
£
100
363,179
363,279
-
(34,059)
(34,059)
100
329,120
329,220
100
329,120
329,220
100
363,179
363,279
Class of
shares
Holding
Included in
consolidation
Ordinary
100% Yes
Profit/(Loss)
for the year
£
Net assets
£
41,304
41,621

Page 32

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2022

13. Debtors

Due within one year
Trade debtors
Amounts owed by group undertakings
Other debtors
Prepayments and accrued income		 2022
£
13,342
41,742
11
2,627
57,722		 2021
£
32,409
48,376
496
1,614
82,895

14. Creditors: Amounts falling due within one year

Trade creditors
PAYE and social security
Accruals and deferred income		 2022
£
5,962
1
13,730
19,693		 2021
£
601
-
10,761
11,362

Page 33

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2022

15. Statement of funds

Statement of funds - current year

Unrestricted funds
General Funds - all funds
Unallocated amounts
Restricted funds
Wolstencroft fund
Journal fund
Gatsby Charitable Foundation
Guarantors of Brain
Equity, diversity and inclusion
(EDI)
Total funds		 Balance at 1
October
2021
£
491,954
-
491,954
6,500
-
35,364
9,792
-
51,656
543,610		 Income
£
216,873
(12,600)
204,273
-
4,776
150,000
-
48,367
203,143
407,416		 Expenditure
£
(149,939)
-
(149,939)
-
(4,476)
(134,287)
-
(30,534)
(169,297)
(319,236)		 Gains/
(Losses)
£
(34,059)
-
(34,059)
-
-
-
-
-
-
(34,059)		 Balance at
30
September
2022
£
524,829
(12,600)
512,229
6,500
300
51,077
9,792
17,833
85,502
597,731

Page 34

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2022

15. Statement of funds (continued)

Statement of funds - prior year

Unrestricted funds
General Funds - all funds
Restricted funds
Wolstencroft fund
Journal fund
Society for Neuroscience
Roche Products
Gatsby Charitable Foundation
Guarantors of Brain
Equity, diversity and inclusion
(EDI)
Total funds		 Balance at
1 October
2020
£
402,202
6,500
3,104
506
5,855
150,585
-
-
166,550
568,752		 Income
£
143,331
-
4,637
-
-
-
10,000
5,529
20,166
20,166		 Expenditure
£
(115,690)
-
(7,741)
(506)
(5,855)
(115,221)
(208)
(5,529)
(135,060)
(250,750)		 Gains/
(Losses)
£
62,111
-
-
-
-
-
-
-
-
62,111		 Balance at
30
September
2021
£
491,954
6,500
-
-
-
35,364
9,792
-
51,656
543,610

Page 35

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2022

15. Statement of funds (continued)

Wolstencroft fund - for expenses in regard to a lecture on ‘Outstanding Neuroscience’ at the biennial BNA Festival.

Journal fund - for editing and general running of the journal.

Society for Neuroscience - for the Core Concepts education project.

Roche Products - to support the continued teaching of neuroscience in UK schools.

Gatsby Charitable Foundation - to support the implementation of the BNA's new strategic plan.

Guarantors of Brain (2021) - funding for Equity, diversity and inclusion (EDI) in neuroscience education

Guarantors of Brain (2020) - funding for BNA's Brain Carer grants programme. The transfer represents expenditure incurred in the prior year in advance of the income being received but originally allocated to unrestricted funds.

Equity, diversity and inclusion (EDI) - funding to support Equity, diversity and inclusion (EDI) in neuroscience education from IBRO, MSD, and Wellcome.

Thriplow Trust

16. Analysis of net assets between funds

Analysis of net assets between funds - current year

Unrestricted
funds
2022
£
Tangible fixed assets
1,353
Fixed asset investments
329,220
Current assets
211,088
Creditors due within one year
(16,832)
Difference
(12,600)
Total
512,229		 Restricted
funds
2022
£
-
-
75,763
(2,861)
12,600
85,502		 Total
funds
2022
£
1,353
329,220
286,851
(19,693)
-
597,731

Page 36

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2022

16. Analysis of net assets between funds (continued)

Analysis of net assets between funds - prior year

Tangible fixed assets
Fixed asset investments
Current assets
Creditors due within one year
Total		 Unrestricted
funds
2021
£
1,803
363,279
133,334
(6,462)
491,954		 Restricted
funds
2021
£
-
-
56,556
(4,900)
51,656		 Total
funds
2021
£
1,803
363,279
189,890
(11,362)
543,610

17. Pension commitments

The Charity operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Charity in an independently administered fund. The pension cost charge represents contributions payable by the Charity to the fund and amounted to £8,711 (2021: £7,621). Contributions of £nil (2021: £nil) were owed to the fund at the balance sheet date.

18. Related party transactions

At 30 September 2022, British Neuroscience Association Limited was owed £41,742 (2021: £48,376) by BNA Events Limited, its wholly-owned subsidiary.

Other than disclosed above or elsewhere in these financial statements, there were no other transactions with related parties requiring disclosure.

Page 37